Niraparib therapy in patients with newly diagnosed advanced ovarian cancer after chemotherapy: PRIMA/ENGOT-OV26/GOG-3012 study Meeting Abstract


Authors: Gonzalez-Martin, A.; Pothuri, B.; Vergote, I.; Christensen, R. D.; Graybill, W.; Mirza, M. R.; McCormick, C.; Lorusso, D.; Hoskins, P.; Freyer, G.; Baumann, K.; Jardon, K.; Redondo, A.; Moore, R. G.; Vulsteke, C.; O'Cearbhaill, R. E.; Lund, B.; Backes, F.; Barretina-Ginesta, P.; Haggerty, A. F.; Rubio-Perez, M. J.; Shahin, M. S.; Mangili, G.; Bradley, W. H.; Bruchim, I.; Sun, K.; Malinowska, I.; Li, Y.; Gupta, D.; Monk, B. J.
Abstract Title: Niraparib therapy in patients with newly diagnosed advanced ovarian cancer after chemotherapy: PRIMA/ENGOT-OV26/GOG-3012 study
Meeting Title: 21st International Meeting of the European Society of Gynaecological Oncology (ESGO)
Journal Title: International Journal of Gynecological Cancer
Volume: 29
Issue: Suppl. 4
Meeting Dates: 2019 Nov 2-5
Meeting Location: Athens, Greece
ISSN: 1048-891X
Publisher: Lippincott Williams & Wilkins  
Date Published: 2019-11-01
Start Page: A9
End Page: A10
Language: English
ACCESSION: WOS:000523502500010
DOI: 10.1136/ijgc-2019-ESGO.9
PROVIDER: wos
Notes: Meeting Abstract -- Source: Wos
Altmetric
Citation Impact
MSK Authors